Wellbutrin vs. Trintellix: Dopamine Boost or Serotonin Fine-Tuning When SSRIs Fail?

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Wellbutrin vs. Trintellix: When SSRIs Help but Something's Still Missing

Your patient's depression is improving. They're less anxious, less tearful, and less reactive. But there's a problem: they still can't feel much joy, struggle with motivation, or complain that their emotions feel flat.

Is this residual depression, SSRI-induced emotional blunting, or both? And should you consider Wellbutrin or Trintellix?

In this episode of Pearls & Prep, NPZ breaks down two unique antidepressants—Wellbutrin (bupropion) and Trintellix (vortioxetine)—and explores how psychiatric nurse practitioners can think through these common prescribing dilemmas.

We'll discuss:

Wellbutrin vs. Trintellix: How their mechanisms of action differ.SSRI emotional blunting: Why patients may feel less sadness but also less joy.Dopamine and serotonin: How these neurotransmitter systems influence reward, motivation, and emotional processing.When to consider Wellbutrin: Low energy, poor motivation, sexual side effects, and residual depressive symptoms.When to consider Trintellix: Depression with cognitive complaints, SSRI tolerability problems, and situations where a serotonergic approach remains desirable.Switching vs. augmentation: Why an effective SSRI shouldn't automatically be abandoned.Clinical precautions: Seizure risk, nausea, medication interactions, and practical prescribing considerations.

This isn't another dry psychopharmacology lecture. It's a real-world conversation about matching antidepressants to patients rather than simply treating a diagnosis.

Whether you're a psychiatric mental health nurse practitioner (PMHNP), NP student, or new psychiatric prescriber, this episode will help sharpen your clinical reasoning around antidepressant selection.